Cerebral amyloid angiopathy and its relationship to Alzheimer’s disease

[1]  Dietmar Rudolf Thal,et al.  Capillary cerebral amyloid angiopathy is associated with vessel occlusion and cerebral blood flow disturbances , 2009, Neurobiology of Aging.

[2]  S. Salloway,et al.  Cerebral Cortical Arteriolar Angiopathy, Vascular Beta-Amyloid, Smooth Muscle Actin, Braak Stage, and APOE Genotype , 2008, Stroke.

[3]  K. Jellinger,et al.  Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy , 2008, Journal of Neurology.

[4]  Phillip B. Jones,et al.  Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. , 2007, Brain : a journal of neurology.

[5]  A. Goate,et al.  Clearance of amyloid-β by circulating lipoprotein receptors , 2007, Nature Medicine.

[6]  Keith A. Johnson,et al.  Imaging of amyloid burden and distribution in cerebral amyloid angiopathy , 2007, Annals of neurology.

[7]  M. Staufenbiel,et al.  Occurrence and co-localization of amyloid β-protein and apolipoprotein E in perivascular drainage channels of wild-type and APP-transgenic mice , 2007, Neurobiology of Aging.

[8]  M. Frosch,et al.  Course of cerebral amyloid angiopathy–related inflammation , 2007, Neurology.

[9]  F. Jessen,et al.  Histologically confirmed amyloid deposition and low CSF Aβ42 in a cognitively normal subject , 2007, Journal of Neurology.

[10]  Keith A. Johnson,et al.  Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. , 2007, Archives of neurology.

[11]  Jean Logan,et al.  Seeing what Alzheimer saw , 2007, Nature Medicine.

[12]  P. Thompson,et al.  PET of brain amyloid and tau in mild cognitive impairment. , 2006, The New England journal of medicine.

[13]  C. Pieper,et al.  The distribution of cerebrovascular amyloid in Alzheimer’s disease varies with ApoE genotype , 2006, Acta Neuropathologica.

[14]  M. Staufenbiel,et al.  Selective vulnerability of different types of commissural neurons for amyloid beta-protein-induced neurodegeneration in APP23 mice correlates with dendritic tree morphology. , 2006, Brain : a journal of neurology.

[15]  G. Plant,et al.  Cerebral Amyloid Angiopathy , 2006 .

[16]  D. Dickson,et al.  Induction of vascular amyloidosis-β by oxidative stress depends on APOE genotype , 2006, Neurobiology of Aging.

[17]  H. Braak,et al.  The development of amyloid beta protein deposits in the aged brain. , 2006, Science of aging knowledge environment : SAGE KE.

[18]  M. Frosch,et al.  The Cerebral β‐Amyloid Angiopathies: Hereditary and Sporadic , 2006 .

[19]  M. Hart.  Pathology & Genetics: Cerebrovascular Diseases , 2005 .

[20]  H. Braak,et al.  Apolipoprotein E co-localizes with newly formed amyloid β-protein (Aβ) deposits lacking immunoreactivity against N-terminal epitopes of Aβ in a genotype-dependent manner , 2005, Acta Neuropathologica.

[21]  L. Feuk,et al.  Sequence variants of IDE are associated with the extent of β-amyloid deposition in the Alzheimer's disease brain , 2005, Neurobiology of Aging.

[22]  Berislav V. Zlokovic,et al.  Neurovascular mechanisms of Alzheimer's neurodegeneration , 2005, Trends in Neurosciences.

[23]  N. Schuff,et al.  Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. , 2005, Radiology.

[24]  Kurt Bürki,et al.  Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis , 2004, Nature Neuroscience.

[25]  Dietmar Rudolf Thal,et al.  Neurodegeneration in normal brain aging and disease. , 2004, Science of aging knowledge environment : SAGE KE.

[26]  H. Cai,et al.  Amyloid β peptide load is correlated with increased β-secretase activity in sporadic Alzheimer's disease patients , 2004 .

[27]  K. Jellinger,et al.  Amyloid β peptide 1–42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology , 2004, Acta Neuropathologica.

[28]  M. Frosch,et al.  Clinical manifestations of cerebral amyloid angiopathy–related inflammation , 2004, Annals of neurology.

[29]  K. Jellinger,et al.  Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology—a pilot study , 2004, Acta Neuropathologica.

[30]  O. Wiestler,et al.  Vascular Pathology in Alzheimer Disease: Correlation of Cerebral Amyloid Angiopathy and Arteriosclerosis/Lipohyalinosis with Cognitive Decline , 2003, Journal of neuropathology and experimental neurology.

[31]  Markus Rudin,et al.  Age-Dependent Impairment of Somatosensory Response in the Amyloid Precursor Protein 23 Transgenic Mouse Model of Alzheimer's Disease , 2003, The Journal of Neuroscience.

[32]  G. Plant,et al.  Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View , 2003, Journal of neuropathology and experimental neurology.

[33]  Michael S. Wolfe,et al.  γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  L. Hersh,et al.  Amyloid-β peptide levels in brain are inversely correlated with insulysin activity levels in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[36]  H. Braak,et al.  Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.

[37]  K. Jellinger,et al.  Alzheimer disease and cerebrovascular pathology: an update , 2002, Journal of Neural Transmission.

[38]  H. Braak,et al.  Two Types of Sporadic Cerebral Amyloid Angiopathy , 2002, Journal of neuropathology and experimental neurology.

[39]  G. Plant,et al.  Familial Danish Dementia: A Novel Form of Cerebral Amyloidosis Associated with Deposition of Both Amyloid‐Dan and Amyloid‐Beta , 2002, Journal of neuropathology and experimental neurology.

[40]  Yu-Min Kuo,et al.  APP Transgenic Mice Tg2576 Accumulate Aβ Peptides That Are Distinct from the Chemically Modified and Insoluble Peptides Deposited in Alzheimer's Disease Senile Plaques† , 2002 .

[41]  T Lashley,et al.  Systemic Amyloid Deposits in Familial British Dementia* , 2001, The Journal of Biological Chemistry.

[42]  D. Mann,et al.  Amyloid angiopathy and variability in amyloid beta deposition is determined by mutation position in presenilin-1-linked Alzheimer's disease. , 2001, The American journal of pathology.

[43]  M. Moskowitz,et al.  Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. , 2001, The American journal of pathology.

[44]  M. Staufenbiel,et al.  Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy , 2001, The Journal of Neuroscience.

[45]  George A. Carlson,et al.  Exogenous Aβ1–40 Reproduces Cerebrovascular Alterations Resulting from Amyloid Precursor Protein Overexpression in Mice , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[46]  C. Iadecola,et al.  Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[47]  H. Braak,et al.  Sequence of Aβ‐Protein Deposition in the Human Medial Temporal Lobe , 2000 .

[48]  L. Thal,et al.  Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4. , 2000, Archives of neurology.

[49]  T. Saido,et al.  Identification of the major Aβ1–42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition , 2000, Nature Medicine.

[50]  B. Sommer,et al.  Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[52]  J. Baron,et al.  Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease. , 1999, Brain : a journal of neurology.

[53]  R. Motter,et al.  Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse , 1999, Nature.

[54]  Agueda Rostagno,et al.  A stop-codon mutation in the BRI gene associated with familial British dementia , 1999, Nature.

[55]  Yu-Min Kuo,et al.  Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. , 1998, The American journal of pathology.

[56]  S. Nakagawa.  Cytological and transcriptional compartments in the cerebellum of the staggerer mouse , 1998 .

[57]  S. Stahl,et al.  The National Institute on Aging. , 1998, Medical care.

[58]  Y. Ihara,et al.  Diffuse plaques associated with astroglial amyloid β protein, possibly showing a disappearing stage of senile plaques , 1998, Acta Neuropathologica.

[59]  W. Markesbery,et al.  N‐terminal Heterogeneity of Parenchymal and Cerebrovascular Aβ Deposits , 1998, Journal of neuropathology and experimental neurology.

[60]  H. Vinters,et al.  Giant cell arteritis in association with cerebral amyloid angiopathy: immunohistochemical and molecular studies. , 1997, Human pathology.

[61]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[62]  H. Braak,et al.  Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.

[63]  S. Greenberg,et al.  Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. , 1997, Stroke.

[64]  John Q. Trojanowski,et al.  Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[65]  M. Bobinski,et al.  Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories , 1997, Neurobiology of Aging.

[66]  M. Tabaton,et al.  Heterogeneity of water‐soluble amyloid β‐peptide in Alzheimer's disease and Down's syndrome brains , 1997, FEBS letters.

[67]  H. Budka,et al.  Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly) , 1996, Neurology.

[68]  J. Trojanowski,et al.  Full-length amyloid-beta (1-42(43)) and amino-terminally modified and truncated amyloid-beta 42(43) deposit in diffuse plaques. , 1996, The American journal of pathology.

[69]  T. Iwatsubo,et al.  Amino- and carboxyl-terminal heterogeneity of β-amyloid peptides deposited in human brain , 1996, Neuroscience Letters.

[70]  L. Forno,et al.  P3 beta-amyloid peptide has a unique and potentially pathogenic immunohistochemical profile in Alzheimer's disease brain. , 1996, The American journal of pathology.

[71]  J. Morris,et al.  Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[72]  M. Yamada,et al.  Immune reactions associated with cerebral amyloid angiopathy. , 1996, Stroke.

[73]  R. Roos,et al.  Hereditary Cerebral Hemorrhage with Amyloidosis‐Dutch type (HCHWA‐D): II ‐ A Review of Histopathological Aspects , 1996, Brain pathology.

[74]  H. Vinters,et al.  Brain Parenchymal and Microvascular Amyloid in Alzheimer's Disease , 1996, Brain pathology.

[75]  R. Roos,et al.  Hereditary Cerebral Hemorrhage with Amyloidosis‐Dutch Type (HCHWA‐D): I ‐ A Review of Clinical, Radiologic and Genetic Aspects , 1996, Brain pathology.

[76]  P. Mcgeer,et al.  Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of β-amyloid protein , 1996, Neuroscience Letters.

[77]  H. Budka,et al.  Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G) , 1996, The American journal of pathology.

[78]  M. Benson.  Leptomeningeal amyloid and variant transthyretins. , 1996, The American journal of pathology.

[79]  D. Selkoe,et al.  Sequence of Deposition of Heterogeneous Amyloid β-Peptides and APO E in Down Syndrome: Implications for Initial Events in Amyloid Plaque Formation , 1996, Neurobiology of Disease.

[80]  B. Ghetti,et al.  Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[81]  L. Thal,et al.  Cerebral infarction in Alzheimer's disease is associated with severe amyloid angiopathy and hypertension. , 1995, Archives of neurology.

[82]  H. Braak,et al.  Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes , 1995, Neuroscience.

[83]  H. Wiśniewski,et al.  In vitro production of β-amyloid in smooth muscle cells isolated from amyloid angiopathy-affected vessels , 1995, Neuroscience Letters.

[84]  R O Weller,et al.  CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance , 1993, Neuropathology and applied neurobiology.

[85]  M J Ball,et al.  beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[86]  Mark S. Greenberg,et al.  Handbook of Neurosurgery , 1993 .

[87]  M J Ball,et al.  Structural alterations in the peptide backbone of beta-amyloid core protein may account for its deposition and stability in Alzheimer's disease. , 1993, The Journal of biological chemistry.

[88]  D. Selkoe,et al.  Amyloid β-peptide is produced by cultured cells during normal metabolism , 1992, Nature.

[89]  Bradley T. Hyman,et al.  Distribution of Alzheimer‐type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease , 1992, Neurology.

[90]  D. Selkoe,et al.  Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments , 1992, Nature.

[91]  J. Vonsattel,et al.  Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study , 1991, Annals of neurology.

[92]  J. Price,et al.  The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease , 1991, Neurobiology of Aging.

[93]  E. Otomo,et al.  Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease , 1991, Brain Research.

[94]  J. Ghiso,et al.  Mutation in gelsolin gene in Finnish hereditary amyloidosis , 1990, The Journal of experimental medicine.

[95]  J. Palo,et al.  Amyloid in familial amyloidosis, Finnish type, is antigenically and structurally related to gelsolin. , 1990, The American journal of pathology.

[96]  I. Lieberburg,et al.  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.

[97]  I. Olafsson,et al.  MUTATION IN CYSTATIN C GENE CAUSES HEREDITARY BRAIN HAEMORRHAGE , 1988, The Lancet.

[98]  D. Selkoe,et al.  Clinically diagnosed Alzheimer's disease: Autopsy results in 150 cases , 1988, Annals of neurology.

[99]  P. S. St George-Hyslop,et al.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. , 1987, Science.

[100]  D. Pollen,et al.  The genetic defect causing familial Alzheimer's disease maps on chromosome 21. , 1987, Science.

[101]  M. Alexander,et al.  Principles of Neural Science , 1981 .

[102]  T. Mandybur.  Cerebral Amyloid Angiopathy: The Vascular Pathology and Complications , 1986, Journal of neuropathology and experimental neurology.

[103]  Luigi Mansi,et al.  Cortical abnormalities in Alzheimer's disease , 1984, Annals of neurology.

[104]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[105]  H. Vinters,et al.  Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. , 1983, Stroke.

[106]  H. Vinters,et al.  Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. , 1983, Stroke.

[107]  R. DeTeresa,et al.  Some morphometric aspects of the brain in senile dementia of the alzheimer type , 1981, Annals of neurology.

[108]  M. Sheridan.  Letter: The handicapped family. , 1975 .

[109]  A. Maloney,et al.  Giant cell arteritis and arteriolitis associated with amyloid angiopathy in an elderly mongol , 1974, Acta Neuropathologica.

[110]  W. Schlote.  Die Amyloidnatur der kongophilen, drusigen Entartung der Hirnarterien (Scholz) im Senium , 1965, Acta Neuropathologica.

[111]  W. Scholz.  Studien zur Pathologie der Hirngefäße II , 1938 .

[112]  Ph. Rezek,et al.  Studien zur Pathologie der Hirngefäße , 1928, Virchows Archiv für Pathologische Anatomie und Physiologie und für Klinische Medizin.

[113]  A. Goate,et al.  Clearance of amyloid-beta by circulating lipoprotein receptors. , 2007, Nature medicine.

[114]  D. Dickson,et al.  Induction of vascular amyloidosis-beta by oxidative stress depends on APOE genotype. , 2006, Neurobiology of aging.

[115]  M. Frosch,et al.  The cerebral beta-amyloid angiopathies: hereditary and sporadic. , 2006, Brain pathology.

[116]  H. Braak,et al.  Apolipoprotein E co-localizes with newly formed amyloid beta-protein (Abeta) deposits lacking immunoreactivity against N-terminal epitopes of Abeta in a genotype-dependent manner. , 2005, Acta neuropathologica.

[117]  H. Cai,et al.  Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[118]  B. Surbek.  L'angiopathie dyshorique (Morel) de l'écorce cérébrale , 2004, Acta Neuropathologica.

[119]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[120]  E. Zhang,et al.  Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain , 2004, Acta Neuropathologica.

[121]  J. Wegiel,et al.  Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease , 2004, Acta Neuropathologica.

[122]  T. Wyss-Coray,et al.  Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. , 2003, Nature medicine.

[123]  M. Staufenbiel,et al.  APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques. , 2002, Biochemistry.

[124]  H. Braak,et al.  Sequence of Abeta-protein deposition in the human medial temporal lobe. , 2000, Journal of neuropathology and experimental neurology.

[125]  H. Braak,et al.  Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex. , 2000, Acta neuropathologica.

[126]  H. Braak,et al.  Amyloid β-protein (Aβ)-containing astrocytes are located preferentially near N-terminal-truncated Aβ deposits in the human entorhinal cortex , 2000, Acta Neuropathologica.

[127]  W. Rosenblum.  Diagnosis of cerebral amyloid angiopathy: sensitivity and specificity of cortical biopsy. , 1997, Stroke.

[128]  D. Teplow,et al.  Amyloid beta-peptide is produced by cultured cells during normal metabolism. , 1992, Nature.

[129]  D. Selkoe,et al.  Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer's disease. An immunoelectron microscopic study. , 1992, The American journal of pathology.

[130]  G. Glenner,et al.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.